|
Brian Mengel,
Civil Servant
|
Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability.
Blood pressure should be monitored frequently and controlled during and following Activase administration in the management of acute ischemic stroke.
|
|
Albert Graham,
Backyard Pool Drainer
|
In acute ischemic stroke, neither the incidence of intracranial hemorrhage nor the benefits of therapy are known in patients treated with Activase more than 3 hours after the onset of symptoms.
Learn to assess and treat patients experiencing an acute myocardial infarction, ischemic stroke, and sudden cardiac arrest.
Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
|
|
Miles Rhodes,
Wine Taster
|
Thrombolytics : Drugs used to treat an ongoing, acute ischemic stroke by dissolving the blood clot causing the stroke and thereby restoring blood flow through the artery.
|
|
Zhang Xian Qian,
Ex-Olympic Swimmer
|
Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study.
Transient ischemic attack, often a precursor to stroke, is an acute episode of temporary loss of cerebral function.
Does the application of Constraint-Induced Movement Therapy during acute rehabilitation reduce arm impairment after ischemic stroke?
|
|
Adam Findley,
Professional Motivator
|
The priority of the Stroke Trials Directory is to list all ongoing and recently completed multicenter, randomized trials of therapeutic interventions for acute ischemic stroke or secondary stroke prevention.
|
|
Arthur Dawkins,
Astro-physicist
|
Cervene (Nalmefene) in acute ischemic stroke: Final results of a phase III efficacy study.
|
|
David Rosenberg,
Dermatologist
|
Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial.
|
|
|
